Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (COLO320HSR)
Assay data:13 Active, 794 Tested
SummaryPubMed CitationRelated BioAssays by Depositor
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW1463)
Assay data:9 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (NCIH716)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HCC2998)
Assay data:10 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (CL40)
Assay data:15 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (LS123)
Assay data:16 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (GP5D)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW1116)
Assay data:7 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (RKO)
Assay data:11 Active, 794 Tested
Inhibition of DAPK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay
Assay data:3 Tested
SummaryPubMed CitationRelated BioAssays by Target
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (C2BBE1)
Assay data:24 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (LS180)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SNU407)
Assay data:12 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (COLO678)
Assay data:22 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (DIFI)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HT115)
Assay data:14 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW48)
Inhibition of human DAPK1 by Off-chip mobility shift assay
Assay data:1 Tested
InfectX: Pathogen infection siRNA screens
Assay data:115372 Tested
SummaryPubMed Citation
Inhibition of human DAPK1 assessed as enzyme activity at 1 uM relative to control
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on